- Home
- HLIO vs SANA Comparison
HLIO vs SANA Comparison
Compare HLIO & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLIO
- SANA
- Stock Information
- Founded
- HLIO 1970
- SANA 2018
- Country
- HLIO United States
- SANA United States
- Employees
- HLIO N/A
- SANA N/A
- Industry
- HLIO Metal Fabrications
- SANA Medicinal Chemicals and Botanical Products
- Sector
- HLIO Industrials
- SANA Health Care
- Exchange
- HLIO Nasdaq
- SANA Nasdaq
- Market Cap
- HLIO 1.2B
- SANA 983.4M
- IPO Year
- HLIO N/A
- SANA 2021
- Fundamental
- Price
- HLIO $35.41
- SANA $3.91
- Analyst Decision
- HLIO Strong Buy
- SANA Strong Buy
- Analyst Count
- HLIO 3
- SANA 6
- Target Price
- HLIO $44.00
- SANA $10.00
- AVG Volume (30 Days)
- HLIO 356.1K
- SANA 5.5M
- Earning Date
- HLIO 08-04-2025
- SANA 08-11-2025
- Dividend Yield
- HLIO 1.02%
- SANA N/A
- EPS Growth
- HLIO 11.74
- SANA N/A
- EPS
- HLIO 1.11
- SANA N/A
- Revenue
- HLIO $789,400,000.00
- SANA N/A
- Revenue This Year
- HLIO N/A
- SANA N/A
- Revenue Next Year
- HLIO $4.48
- SANA N/A
- P/E Ratio
- HLIO $31.88
- SANA N/A
- Revenue Growth
- HLIO N/A
- SANA N/A
- 52 Week Low
- HLIO $24.76
- SANA $1.26
- 52 Week High
- HLIO $57.29
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- HLIO 48.32
- SANA 47.52
- Support Level
- HLIO $35.56
- SANA $4.72
- Resistance Level
- HLIO $38.70
- SANA $5.33
- Average True Range (ATR)
- HLIO 1.27
- SANA 0.35
- MACD
- HLIO -0.21
- SANA -0.14
- Stochastic Oscillator
- HLIO 32.16
- SANA 3.40
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.